Elsevier invites you to participate in a very important global census which will benefit the medical community. Your input will influence the critical knowledge base that we are creating to improve relevant medical learning and patient outcomes for Vascular/Metabolic Disease.

SO JOIN US TO MAKE A DIFFERENCE TODAY!

Why this census now?

• The World Health Organization (WHO) reports that cardiovascular disease is the leading cause of death worldwide and there are 1.6 billion overweight and 400 million obese adults worldwide (WHO, 2005 projections). Also The International Diabetes Federation estimates by 2025 there will be 438 million diabetic patients (7.8% of the world population).
• To better understand what is really occurring in today's medical and clinical treatment of vascular and metabolic diseases, our census is asking for your "real world," not "ideal," responses.
• The sooner we have your valuable input, the sooner we can analyze the data and provide you with timely information that will help researchers and healthcare providers build new treatment paradigms to improve patient outcomes.

What does this mean to me?

• Participate with >350,000 clinicians in the largest survey of its kind
• Relevancy to your practice: Provides your Journal Editors with valuable data to communicate what this information means for your journal's content, your professional practice, and for you.
• See instant results on key controversial questions
• Receive Free CE and CME credit and a Free Journal Subscription
• All answers are confidential -- personal information will not be passed on

(When finished you can view Instant Results to several key questions.)

Ex.: INSTANT RESULT QUESTION #2:

Many drugs you prescribe have "off-target" side effects -
eg, NSAIDs raise BP, PPARs may increase risk of MI, etc.
When balancing benefit vs potential harm, do you believe
the decision whether to prescribe a particular therapy,
knowing it may cause harm, should be

	A. for the individual physician to decide, in consultation with the individual patient
	B. set by law (through the regulatory review process), so there is the least possible legal ambiguity
	C. prescribed by your professional societies, on the basis of consensus statements and guidelines
	D. determined by third party payers (eg, insurance companies)
	E. resolved by improved doctor and patient education

After completing the census you will return to this page so that immediately, or at a later time, you can view: